Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2021 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Oncolytic virus-mediated reducing of myeloid-derived suppressor cells enhances the efficacy of PD-L1 blockade in gemcitabine-resistant pancreatic cancer.
Cancer Immunol Immunother. 2023 May;72(5):1285-1300. doi: 10.1007/s00262-022-03334-x. Epub 2022 Nov 27.
Cancer Immunol Immunother. 2023.
PMID: 36436021
Free PMC article.
Extracellular vesicles shed from gastric cancer mediate protumor macrophage differentiation.
Ito A, Kagawa S, Sakamoto S, Kuwada K, Kajioka H, Yoshimoto M, Kikuchi S, Kuroda S, Yoshida R, Tazawa H, Fujiwara T.
Ito A, et al.
BMC Cancer. 2021 Jan 28;21(1):102. doi: 10.1186/s12885-021-07816-6.
BMC Cancer. 2021.
PMID: 33509150
Free PMC article.
Item in Clipboard
The epithelial-to-mesenchymal transition induced by tumor-associated macrophages confers chemoresistance in peritoneally disseminated pancreatic cancer.
Kuwada K, Kagawa S, Yoshida R, Sakamoto S, Ito A, Watanabe M, Ieda T, Kuroda S, Kikuchi S, Tazawa H, Fujiwara T.
Kuwada K, et al.
J Exp Clin Cancer Res. 2018 Dec 11;37(1):307. doi: 10.1186/s13046-018-0981-2.
J Exp Clin Cancer Res. 2018.
PMID: 30537992
Free PMC article.
Item in Clipboard
Cite
Cite